S. 3267

119 S3267 IS: Alzheimer's Screening and Prevention Act
 U.S. Senate
 2025-11-20
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 II  119th CONGRESS  1st Session  S. 3267  IN THE SENATE OF THE UNITED STATES   November 20, 2025   Ms. Collins  (for herself,  Ms. Cortez Masto ,  Mrs. Capito , and  Mr. Warner ) introduced the following bill; which was read twice and referred to the  Committee on Finance    A BILL
To amend title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests.
1.
Short title
This Act may be cited as the   Alzheimer's Screening and Prevention Act   or the   ASAP Act  .
2.
Medicare coverage of Alzheimer’s disease and related dementias early detection screening tests
(a)
Coverage
Section 1861 of the Social Security Act ( 42 U.S.C. 1395x ) is amended—
(1)
in subsection (s)(2)—
(A)
in subparagraph (JJ), by striking the semicolon at the end and inserting  ; and ; and
(B)
by adding at the end the following new subparagraph:
(KK)
Alzheimer’s disease and related dementias early detection screening tests (as defined in subsection (nnn));
  and
(2)
by adding at the end the following new subsection:
(nnn)
Alzheimer’s disease and related dementias early detection screening tests
The term  Alzheimer’s disease and related dementias early detection screening test  means a test furnished to an individual for the detection of the pre-symptomatic and early stage of Alzheimer’s disease or related dementias on or after January 1, 2028, that—
(1)
is cleared under section 510(k), classified under section 513(f)(2), or approved under section 515 of the Federal Food, Drug, and Cosmetic Act; and
(2)
is—
(A)
a genomic sequencing blood or blood product test; or
(B)
such other equivalent test, including a single-analyte test, blood test analysis of cell-free nucleic acids, multiplex panel test, whole genome sequencing, protein expression, whole exome, whole transcriptome, and medical imaging (which are based on blood, blood products, tissue, urine or other biospecimen), as the Secretary determines appropriate in providing results comparable to those obtained with a test described in subparagraph (A).
 .
(b)
Payment
Section 1833(h)(1)(A) of the Social Security Act ( 42 U.S.C. 1395l(h)(1)(A) ) is amended by inserting  Alzheimer’s disease and related dementias early detection screening tests under section 1861(nnn) and  after  including .